Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q4 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
0.00%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 690 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$11.17M
Net Profit Margin
-2406.00%
TTM Avg
-2017.47%
3Y Avg
-5077.56%
5Y Avg
-6322.50%
Market Cap
$11.21M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$11.30M
Net Profit Margin
0.00%
TTM Avg
11.23%
3Y Avg
5.62%
5Y Avg
-9479.86%
Market Cap
$10.93M
Net Profit Margin
-14621.00%
TTM Avg
-5877.48%
3Y Avg
-2938.74%
5Y Avg
-1959.16%
Market Cap
$10.77M
Net Profit Margin
N/A
TTM Avg
-2424.09%
3Y Avg
-1624.47%
5Y Avg
-1082.98%
Market Cap
$11.44M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$11.22M
Net Profit Margin
-620.70%
TTM Avg
-326.13%
3Y Avg
-2493.66%
5Y Avg
-2115.74%
Market Cap
$10.57M
Net Profit Margin
-141.28%
TTM Avg
-101.58%
3Y Avg
-179.50%
5Y Avg
-204.48%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioVie Inc. (BIVI) | $11.09M | 0.00% | 0.00% | 0.00% | 0.00% |
| Pluri Inc. (PLUR)vs › | $11.17M | -2406.00% | -2017.47% | -5077.56% | -6322.50% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.30M | 0.00% | 11.23% | 5.62% | -9479.86% |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.93M | -14621.00% | -5877.48% | -2938.74% | -1959.16% |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.77M | N/A | -2424.09% | -1624.47% | -1082.98% |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.44M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cerenome, Inc. (CNSY)vs › | $11.22M | -620.70% | -326.13% | -2493.66% | -2115.74% |
| Lifeward Ltd. (LFWD)vs › | $10.57M | -141.28% | -101.58% | -179.50% | -204.48% |
| Biofrontera Inc. (BFRI)vs › | $11.82M | -13.78% | -36.44% | -33.55% | -58.16% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
